Open Access


Read more
image01

Online Manuscript Submission


Read more
image01

Submitted Manuscript Trail


Read more
image01

Online Payment


Read more
image01

Online Subscription


Read more
image01

Email Alert



Read more
image01

Original Research Article | OPEN ACCESS

Diosmetin alleviates periodontitis by inhibiting oxidative stress and pyroptosis via Nrf2/NF-κB/NLRP3 axis

Mingxuan Cheng1, Pu Wang2, Di Wu3

1Department of Prosthodontics, Peking University Hospital of Stomatology First Clinical Division, Beijing 100034, China; 2School of Stomatology, Peking University School and Hospital of Stomatology, Beijing 100081, China; 3Department of Stomatology, Lishui People’s Hospital (The 6th Affiliated Hospital of Wenzhou Medical University), Lishui City, Zhejiang Province 323020, China.

For correspondence:-  Di Wu   Email: di_w10@163.com   Tel:+865782187178

Accepted: 30 October 2022        Published: 30 November 2022

Citation: Cheng M, Wang P, Wu D. Diosmetin alleviates periodontitis by inhibiting oxidative stress and pyroptosis via Nrf2/NF-κB/NLRP3 axis. Trop J Pharm Res 2022; 21(11):2303-2308 doi: 10.4314/tjpr.v21i11.5

© 2022 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To investigate the therapeutic role of diosmetin on periodontitis and its possible mechanism of action.
Methods: Lipopolysaccharide (LPS) was used to induce periodontitis in periodontal cells. Cell viability and apoptosis in response to LPS and diosmetin were evaluated using t MTT and TUNEL assays, while oxidative stress and inflammatory responses in LPS-induced periodontitis and diosmetin effects in periodontal cells were determined by enzyme-linked immunosorbent (ELISA) assays. In addition, the roles of diosmetin in pyroptosis and Nrf2/NF-kappa B/NLRP3 pathway were evaluated by immunoblot assay.
Results: Diosmetin increased the viability of LPS-induced periodontal cells (p < 0.01), and also alleviated the oxidative stress of periodontal cells (p < 0.01). It reduced the secretion of proinflammatory factors in periodontal cells and inhibited cell pyroptosis (p < 0.01). Furthermore, it mediated Nrf2/NF-kappa B/NLRP3 pathway (p < 0.01).
Conclusion: Diosmetin alleviates periodontitis by inhibiting oxidative stress and pyroptosis through Nrf2/NF-κB/NLRP3 axis. Therefore, it can potentially be used for the management of periodontitis.

Keywords: Purpose: To investigate the therapeutic role of diosmetin on periodontitis and its possible mechanism of action. Methods: Lipopolysaccharide (LPS) was

Impact Factor
Thompson Reuters (ISI): 0.6 (2023)
H-5 index (Google Scholar): 49 (2023)

Article Tools

Share this article with



Article status: Free
Fulltext in PDF
Similar articles in Google
Similar article in this Journal:

Archives

2024; 23: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10
2023; 22: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2022; 21: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2021; 20: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2020; 19: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2019; 18: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2018; 17: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2017; 16: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2016; 15: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2015; 14: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2014; 13: 
1,   2,   3,   4,   5,   6,   7,   8,   9,   10,   11,   12
2013; 12: 
1,   2,   3,   4,   5,   6
2012; 11: 
1,   2,   3,   4,   5,   6
2011; 10: 
1,   2,   3,   4,   5,   6
2010; 9: 
1,   2,   3,   4,   5,   6
2009; 8: 
1,   2,   3,   4,   5,   6
2008; 7: 
1,   2,   3,   4
2007; 6: 
1,   2,   3,   4
2006; 5: 
1,   2
2005; 4: 
1,   2
2004; 3: 
1
2003; 2: 
1,   2
2002; 1: 
1,   2

News Updates